Group 1 - The first meeting of the third board of directors of Beijing Shenzhou Cell Biotechnology Group Co., Ltd. was held on May 16, 2025, with all seven directors present, confirming the legality and validity of the meeting [1][2] - The board unanimously elected Mr. Xie Liangzhi as the chairman of the third board of directors, with a term starting from the approval date until the end of the board's term [1][2] - The board approved the establishment of specialized committees under the board, including the Strategy Committee, Audit Committee, and Nomination and Remuneration Committee, with specific members and conveners appointed for each committee [2][3] Group 2 - Mr. Xie Liangzhi was appointed as the general manager of the company, with a term starting from the approval date until the end of the board's term [2][3] - Mr. Yang Wang and Mr. Tang Liming were appointed as deputy general managers, with the same term conditions [3][4] - Ms. Ma Jie was appointed as the financial director, and Mr. Tang Liming was appointed as the board secretary, both with terms aligned with the board's duration [3][4]
神州细胞: 神州细胞第三届董事会第一次会议决议公告